• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human GPBP1L1 Polyclonal Antibody

The antibody against GPBP1L1 was raised in rabbit using the Human GPBP1L1 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.

ADC-48431A

The antibody against GPBP1L1 was raised in rabbit using the Human GPBP1L1 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.

$600.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-48431A ClonalityPolyclonal
Host SpeciesRabbitTarget NameGPBP1L1
Target SynonymsGPBP1L1 antibody; SP192Vasculin-like protein 1 antibody; GC-rich promoter-binding protein 1-like 1 antibodyFormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, Avoid freeze / thaw cycles., PBS with 0.1% Sodium AzidePurification MethodAntigen affinity purified
ConjugateNon-conjugatedApplicationELISA, WB
StorageUpon receipt

Immunogen Information


Immunogen DescriptionHuman GPBP1L1Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ9HC44
Background Information
  • Uniprot Id

    Q9HC44

  • Target Species

    Human

  • Target Name

    GPBP1L1

  • Target Full Name

    Vasculin-like protein 1

  • Target Function

    Possible transcription factor.

  • Target Subcellular Location

    Nucleus.

  • Target Protein Families

    Vasculin family

  • Target Synonyms

    GPBP1L1; SP192Vasculin-like protein 1; GC-rich promoter-binding protein 1-like 1

Inquire Rabbit anti-Human GPBP1L1 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification